US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Boundless Bio, Inc.

1.05

-0.0400-3.67%

Post-market: 1.050.00000.00%19:02 EDT

Volume:122.05K

Turnover:130.45K

Market Cap:23.50M

PE:-0.36

High:1.12

Open:1.07

Low:1.04

Close:1.09

Loading ...

Overview Company News Filings

Boundless Bio Q1 EPS $(0.71) Beats $(0.73) Estimate

Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights

THOMSON REUTERS

Boundless Bio Inc: $138 Mln Cash Position Provides Operating Runway Into 2027

THOMSON REUTERS

Press Release: Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights

New Strong Sell Stocks for May 1st

BILI Social, Part of Allied Energy Inc. (OTC:AGGI), Wins Three Global Awards for Creator-Led Campaigns at BOLD Awards VI

Boundless Bio to Participate in the Needham Virtual Healthcare Conference

Analysts Offer Insights on NA Companies: Kyverna Therapeutics, Inc. (KYTX) and Boundless Bio Inc. (BOLD)

Boundless Bio Files $400 Million Mixed Shelf

MT Newswires Live

BRIEF-Boundless Bio Inc Files For Mixed Shelf Of Up To $400 Million – SEC Filing

Boundless Bio : Sales Agreement Prospectus Covering Offering of up to $14.5 Million of Common Stock

THOMSON REUTERS

Boundless Bio Inc Files for Mixed Shelf of up to $400 Mln – SEC Filing

THOMSON REUTERS

Guggenheim Sticks to Its Hold Rating for Boundless Bio Inc. (BOLD)

Boundless Bio’s 2024 Financial Results and Strategic Progress

BRIEF-Boundless Bio Reports Fourth Quarter And Full Year 2024 Financial Results And Business Highlights

Boundless Bio Q4 2024 GAAP EPS $(0.74) Beats $(0.77) Estimate

Boundless Bio Inc: Qtrly Shr Loss $0.74

THOMSON REUTERS

Press Release: Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

North American Morning Briefing: Stock Futures Fall as Focus Shifts From Fed to Tariffs

Press Release: TACO BELL(R) UNVEILS BOLD BUSINESS STRATEGY FOR A RELENTLESSLY INNOVATIVE FUTURE

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BOLD/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BOLD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BOLD\",,,,,undefined,":{"symbol":"BOLD","market":"US","secType":"STK","nameCN":"Boundless Bio, Inc.","latestPrice":1.05,"timestamp":1749844800000,"preClose":1.09,"halted":0,"volume":122045,"hourTrading":{"tag":"盘后","latestPrice":1.05,"preClose":1.05,"latestTime":"19:02 EDT","volume":1959,"amount":2056.95,"timestamp":1749855755140},"delay":0,"floatShares":14281419,"shares":22384130,"eps":-2.953134,"marketStatus":"Market Closed","change":-0.04,"latestTime":"06-13 16:00:00 EDT","open":1.07,"high":1.124,"low":1.04,"amount":130452.33832400001,"amplitude":0.077064,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.953134,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750060800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1711598400000,"exchange":"NASDAQ","adjPreClose":1.09,"preHourTrading":{"tag":"盘前","latestPrice":1.14,"preClose":1.09,"latestTime":"08:49 EDT","volume":901,"amount":998.7428226000001,"timestamp":1749818982983},"postHourTrading":{"tag":"盘后","latestPrice":1.05,"preClose":1.05,"latestTime":"19:02 EDT","volume":1959,"amount":2056.95,"timestamp":1749855755140},"volumeRatio":0.26313271351901224},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BOLD\",,,,,undefined,":{"symbol":"BOLD","floatShares":14281419,"roa":"-29.89%","roe":"-54.06%","lyrEps":-3.848504,"volumeRatio":0.26313271351901224,"shares":22384130,"dividePrice":0,"high":1.124,"amplitude":0.077064,"preClose":1.09,"low":1.04,"week52Low":1.04,"pbRate":"0.17","week52High":7.55,"institutionHeld":0,"latestPrice":1.05,"eps":-2.953134,"divideRate":0,"volume":122045,"delay":0,"ttmEps":-2.953134,"open":1.07,"prevYearClose":2.9,"prevWeekClose":1.18,"prevMonthClose":1.1,"prevQuarterClose":1.51,"fiveDayClose":1.18,"twentyDayClose":1.69,"sixtyDayClose":1.57},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BOLD\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2534107073","title":"Boundless Bio Q1 EPS $(0.71) Beats $(0.73) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2534107073","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534107073?lang=en_us&edition=fundamental","pubTime":"2025-05-09 19:19","pubTimestamp":1746789579,"startTime":"0","endTime":"0","summary":"Boundless Bio (NASDAQ:BOLD) reported quarterly losses of $(0.71) per share which beat the analyst consensus estimate of $(0.73) by 2.74 percent. This is a 94.21 percent increase over losses of $(12.27) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45314268/boundless-bio-q1-eps-0-71-beats-0-73-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOLD"],"gpt_icon":0},{"id":"2534921102","title":"Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2534921102","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534921102?lang=en_us&edition=fundamental","pubTime":"2025-05-09 19:00","pubTimestamp":1746788401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nTUA9Y349L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2534022341","title":"Boundless Bio Inc: $138 Mln Cash Position Provides Operating Runway Into 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2534022341","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534022341?lang=en_us&edition=fundamental","pubTime":"2025-05-09 19:00","pubTimestamp":1746788401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nTUA9Y349L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2534104485","title":"Press Release: Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2534104485","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534104485?lang=en_us&edition=fundamental","pubTime":"2025-05-09 19:00","pubTimestamp":1746788400,"startTime":"0","endTime":"0","summary":"Initial proof-of-concept data from the ongoing BBI-355 Phase 1/2 POTENTIATE trial in patients with oncogene-amplified cancers anticipated in the second half of 2025. Novel Kinesin program on track for mid-2025 development candidate nomination and IND filing in the first half of 2026. $138 million cash position provides operating runway into 2027. SAN DIEGO, May 09, 2025  -- Boundless Bio , a clinical-stage oncology company interrogating extrachromosomal DNA  biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced financial results and business highlights for the fiscal quarter ended March 31, 2025.\"Boundless remains committed to delivering new therapeutic options to patients with high unmet need oncogene amplified cancers,\" said Zachary Hornby, President and CEO of Boundless Bio. \"We look forward to providing a clinical data update on our BBI-355 program later this year. Additionally, we expect to nominate a develo","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOLD","RNR","LU2244417387.USD","BK4139","BK4019","LU0077335932.USD","LU0187121727.USD"],"gpt_icon":0},{"id":"2532600508","title":"New Strong Sell Stocks for May 1st","url":"https://stock-news.laohu8.com/highlight/detail?id=2532600508","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532600508?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:23","pubTimestamp":1746102180,"startTime":"0","endTime":"0","summary":"Here are three stocks added to the Zacks Rank #5  List today:. Amplify Energy AMPY is an oil and natural gas company which is engaged in the acquisition, development, exploration and production of oil and natural gas properties. The Zacks Consensus Estimate for its current year earnings has been revised 48.5% downward over the last 60 days.AST SpaceMobile ASTS is building the world’s first and only global cellular broadband network in space, accessible directly by standard smartphones  for commercial and government use, leveraging its extensive Intellectual Property and patent portfolio. The Zacks Consensus Estimate for its current year earnings has been revised 12.1% downward over the last 60 days.Boundless Bio, Inc. BOLD is a clinical stage oncology company which is interrogating extrachromosomal DNA biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers. The Zacks Consensus Estimate for its current year earnings has been revise","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/strong-sell-stocks-may-1st-122300809.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AMPY","BK4213","BOLD","BK4089","ASTS","BK4139"],"gpt_icon":0},{"id":"2526582573","title":"BILI Social, Part of Allied Energy Inc. (OTC:AGGI), Wins Three Global Awards for Creator-Led Campaigns at BOLD Awards VI","url":"https://stock-news.laohu8.com/highlight/detail?id=2526582573","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526582573?lang=en_us&edition=fundamental","pubTime":"2025-04-09 05:11","pubTimestamp":1744146660,"startTime":"0","endTime":"0","summary":"BILI Social, a social commerce platform recognized for breakthrough marketing work with clients, Finish  and Dr. Oetker  at international innovation event in Lisbon. BILI Social Wins Three Global Awards for Creator-Led Campaigns at BOLD Awards VI. Adrian Capobianco CEO BILI Social at BOLD Awards VI. MIAMI and TORONTO, April 08, 2025  -- BILI SOCIAL, an indirect subsidiary of Allied Energy Inc , is the social commerce platform redefining how creators and brands connect, made waves on the international scene last week, taking home three awards at a global innovation event in Lisbon, Portugal. The winning campaigns - each rooted in authentic, creator-led content – were developed in partnership with top brands Finish and Giuseppe Pizza .Boldest Sustainability – Finish, “The Torture Test Challenge”BILI partnered with Finish to launch a content-first campaign that tackled tough dish cleaning while also addressing water conservation in a fun, relatable way. This tongue-in-cheek campaign chall","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bili-social-part-allied-energy-211100333.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4509","BOLD","BK4085","BK4563","BK4531","BK4510","BK4077","BK4554","BK4585","BK4505","BK4548","BK4577","BK4588","BK4566","BK4504","AGGI","BK4503","BK4526","BK4513"],"gpt_icon":1},{"id":"2524548230","title":"Boundless Bio to Participate in the Needham Virtual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2524548230","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524548230?lang=en_us&edition=fundamental","pubTime":"2025-04-03 19:00","pubTimestamp":1743678000,"startTime":"0","endTime":"0","summary":"SAN DIEGO, April  03, 2025  (GLOBE NEWSWIRE) -- Boundless Bio(Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/03/3054975/0/en/Boundless-Bio-to-Participate-in-the-Needham-Virtual-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOLD","BK4137","HCSG","BK4139"],"gpt_icon":0},{"id":"2524419464","title":"Analysts Offer Insights on NA Companies: Kyverna Therapeutics, Inc. (KYTX) and Boundless Bio Inc. (BOLD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524419464","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524419464?lang=en_us&edition=fundamental","pubTime":"2025-04-03 00:20","pubTimestamp":1743610809,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Kyverna Therapeutics, Inc. (KYTX – Research Report) and Boun...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-kyverna-therapeutics-inc-kytx-and-boundless-bio-inc-bold?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-kyverna-therapeutics-inc-kytx-and-boundless-bio-inc-bold?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NA","KYTX","BOLD","BK4141","BK4139"],"gpt_icon":0},{"id":"2524124806","title":"Boundless Bio Files $400 Million Mixed Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2524124806","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524124806?lang=en_us&edition=fundamental","pubTime":"2025-04-02 05:02","pubTimestamp":1743541355,"startTime":"0","endTime":"0","summary":"Boundless Bio  filed a mixed shelf registration statement to raise $400 million from the sale of any combination of several securities, according to a Tuesday filing.The filing covers common stock, preferred stock, debt securities, warrants, and units.The sale of the securities will be held \"from time to time,\" the company said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2524864129","title":"BRIEF-Boundless Bio Inc Files For Mixed Shelf Of Up To $400 Million – SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2524864129","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524864129?lang=en_us&edition=fundamental","pubTime":"2025-04-02 04:08","pubTimestamp":1743538097,"startTime":"0","endTime":"0","summary":"BRIEF-Boundless Bio Inc Files For Mixed Shelf Of Up To $400 Million – SEC FilingApril 1  - Boundless Bio Inc BOLD.O:BOUNDLESS BIO INC FILES FOR MIXED SHELF OF UP TO $400 MILLION – SEC FILINGBOUNDLESS BIO : SALES AGREEMENT PROSPECTUS COVERING OFFERING OF UP TO $14.5 MILLION OF COMMON STOCKSource text: [ID:n0001193125-25-070393]Further company coverage: BOLD.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nFWN3QF117:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2524126276","title":"Boundless Bio : Sales Agreement Prospectus Covering Offering of up to $14.5 Million of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2524126276","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524126276?lang=en_us&edition=fundamental","pubTime":"2025-04-02 04:02","pubTimestamp":1743537770,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nFWN3QF117:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2524126223","title":"Boundless Bio Inc Files for Mixed Shelf of up to $400 Mln – SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2524126223","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524126223?lang=en_us&edition=fundamental","pubTime":"2025-04-02 04:02","pubTimestamp":1743537770,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nFWN3QF117:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2523605420","title":"Guggenheim Sticks to Its Hold Rating for Boundless Bio Inc. (BOLD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2523605420","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523605420?lang=en_us&edition=fundamental","pubTime":"2025-03-30 21:55","pubTimestamp":1743342904,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Michael Schmidt maintained a Hold rating on Boundless Bio Inc. (BOLD – Research Report) on March 28. The company’s shares closed...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-its-hold-rating-for-boundless-bio-inc-bold?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-its-hold-rating-for-boundless-bio-inc-bold?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BOLD"],"gpt_icon":0},{"id":"2523668733","title":"Boundless Bio’s 2024 Financial Results and Strategic Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2523668733","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523668733?lang=en_us&edition=fundamental","pubTime":"2025-03-29 12:02","pubTimestamp":1743220977,"startTime":"0","endTime":"0","summary":"Boundless Bio Inc. ( ($BOLD) ) has released its Q4 earnings. Here is a breakdown of the information Boundless Bio Inc. presented to its investors. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/boundless-bios-2024-financial-results-and-strategic-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/boundless-bios-2024-financial-results-and-strategic-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065732104.USD","BOLD","BK4097","PRGS","BK4139"],"gpt_icon":0},{"id":"2522737175","title":"BRIEF-Boundless Bio Reports Fourth Quarter And Full Year 2024 Financial Results And Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2522737175","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522737175?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:41","pubTimestamp":1743075696,"startTime":"0","endTime":"0","summary":"BRIEF-Boundless Bio Reports Fourth Quarter And Full Year 2024 Financial Results And Business HighlightsMarch 27 (Reuters) - Boundless Bio Inc BOLD.O:BOUNDLESS BIO REPORTS FOURTH QUARTER AND FULL YEAR ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA2B54XP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2522375428","title":"Boundless Bio Q4 2024 GAAP EPS $(0.74) Beats $(0.77) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2522375428","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522375428?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:08","pubTimestamp":1743073681,"startTime":"0","endTime":"0","summary":"Boundless Bio Q4 2024 GAAP EPS $(0.74) Beats $(0.77) Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44510934/boundless-bio-q4-2024-gaap-eps-0-74-beats-0-77-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOLD"],"gpt_icon":0},{"id":"2522375436","title":"Boundless Bio Inc: Qtrly Shr Loss $0.74","url":"https://stock-news.laohu8.com/highlight/detail?id=2522375436","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522375436?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:00","pubTimestamp":1743073202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA2B54XP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2522334375","title":"Press Release: Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2522334375","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522334375?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:00","pubTimestamp":1743073200,"startTime":"0","endTime":"0","summary":"BBI-355 Phase 1/2 POTENTIATE trial ongoing in patients with oncogene amplified cancers, with initial proof of concept data expected in the second half of 2025. \"We made important strides in 2024 as we became a public company and continued to advance BBI-355, our oral, selective CHK1 inhibitor in the Phase 1/2 POTENTIATE trial in patients with oncogene amplified cancers, and we look forward to reporting preliminary proof-of-concept data in the second half of this year,\" said Zachary Hornby, President and CEO of Boundless Bio. \"Additionally, we have continued to identify new targets and are advancing an oral degrader of a novel kinesin identified by our Spyglass platform. We are on track to nominate a development candidate for our Kinesin program by mid-year, with the intention to submit an IND in the first half of 2026. We look forward to the year ahead as we continue to advance our pipeline to address the significant unmet need in patients with oncogene amplified cancers.\". BBI-355, a ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2521037934","title":"North American Morning Briefing: Stock Futures Fall as Focus Shifts From Fed to Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2521037934","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521037934?lang=en_us&edition=fundamental","pubTime":"2025-03-21 18:02","pubTimestamp":1742551320,"startTime":"0","endTime":"0","summary":"The euphoria from the Federal Reserve's policy meeting didn't last long.Stock futures were lower Friday as attention shifted from the Fed to the prospect of further tariffs.Trump said in a social media post that the planned imposition of reciprocal tariffs on April 2 would be \"Liberation Day\" in the U.S.\"We maintain our view that the FOMC outcome was effectively a one-day move, with minimal legacy in terms of immediate direction. That said, we also view the FOMC outcome as a whole as nodding towards dovishness, but with numerous caveats,\" ING said.Quantum-computing stocks  are likely to be in focus after suffering steep falls on Thursday as investors appeared unimpressed by their contributions to Nvidia's Quantum Day at its GTC developers' event.The market also faces a test as an estimated $4.5 trillion in options contracts expire, which could increase volatility.FedEx fell 5.1% off hours after it cut its outlook for the year.Lennar management warned investors of a weak housing market.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDY","IMRX","US12M.BOND","US3Y.BOND","DXYN","2NVD.UK","JVA","SNVD.UK","US30Y.BOND","GORV","ADVM","NVD3.UK","ET","ZBIO","SMXT","NVD2.UK","US6M.BOND","IMNM","PURE","US7Y.BOND","MPU","NVDA","NVDL","NVDS.UK","NGNE","NVDU","US5Y.BOND","NVDS","USAU","ATXI","FBRX","BOLD","CCL","3NVD.UK","US2Y.BOND","IRD","XOMA","FBLG","NVDX","SGMA","US10Y.BOND","PRPH","AFG","NVDD","NVIW.SI","CKPT","DM","BPTH","OLMA"],"gpt_icon":1},{"id":"2516567677","title":"Press Release: TACO BELL(R) UNVEILS BOLD BUSINESS STRATEGY FOR A RELENTLESSLY INNOVATIVE FUTURE","url":"https://stock-news.laohu8.com/highlight/detail?id=2516567677","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516567677?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:19","pubTimestamp":1741094340,"startTime":"0","endTime":"0","summary":"With ambitions to double innovation, the brand is sharing exclusive. -- Taco Bell announces its business growth plan, R.I.N.G. The Bell:. -- After reaching a milestone of $1 billion in operating profit in 2024,Taco Bell launches off last year's momentum to drive double the. -- Ahead of Live Ms LIVE 2025, Taco Bell reveals how it aims to. redefine its global brand experience across menus, service, operations. -- Stay up to date with Live Ms LIVE 2025 on social and. year of innovation on and off the menu, Taco Bell is giving investors. and fans alike even more reason to believe in the brand's magic for. Taco Bell is sharing its business strategy via a unique investor event,the product previews coming tonight at Live Ms LIVE, Taco Bell is. \"People love our brand because we do things differently,\" said Sean. Tresvant, CEO of Taco Bell. \"But we also mean business; we have a strong. strategy that keeps our consumers and restaurant teams top of mind. The. Despite industry-wide headwinds, Taco","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4232","BK4596","FOR","LU1804176565.USD","LU2133065610.SGD","BK4595","BK4209","BK4504","BK4516","BK4585","YUM","R","BK4600","LU2265009873.SGD","BK4024","BK4023","BOLD","STRK","BK4588","TACO","BK4022"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":48,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BOLD\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BOLD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BOLD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.3333,"hold":0.6667,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6667,"analysts":3,"updateTime":1748923200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BOLD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BOLD","date":"2025-06-13","current":-0.371416,"percent":0.993399,"low":-7.197589,"twenty":-1.883418,"median":-1.150761,"eighty":-0.59381,"high":-0.361194,"avg":-1.667828,"sd":1.500591,"marketCap":24398701},"quantilePoints":[{"date":"2024-03-28","current":-7.197589,"twenty":-7.197589,"median":-7.197589,"eighty":-7.197589,"marketCap":355805632},{"date":"2024-04-05","current":-5.848041,"twenty":-6.410353,"median":-6.108954,"eighty":-6.050474,"marketCap":289092076},{"date":"2024-04-12","current":-5.231748,"twenty":-6.126948,"median":-5.947008,"eighty":-5.398192,"marketCap":258626218},{"date":"2024-04-19","current":-5.083297,"twenty":-6.09096,"median":-5.501658,"eighty":-5.078799,"marketCap":251287727},{"date":"2024-04-26","current":-5.429681,"twenty":-6.050474,"median":-5.339712,"eighty":-4.853874,"marketCap":268410873},{"date":"2024-05-03","current":-4.071136,"twenty":-5.947008,"median":-5.193511,"eighty":-4.750409,"marketCap":201252560},{"date":"2024-05-10","current":-4.093629,"twenty":-5.848041,"median":-5.078799,"eighty":-4.498493,"marketCap":202364453},{"date":"2024-05-17","current":-4.480499,"twenty":-5.605123,"median":-4.907856,"eighty":-4.413022,"marketCap":221489005},{"date":"2024-05-24","current":-4.735651,"twenty":-5.429681,"median":-4.853874,"eighty":-4.413022,"marketCap":234102149},{"date":"2024-05-31","current":-3.818758,"twenty":-5.40449,"median":-4.780666,"eighty":-4.267271,"marketCap":202947870},{"date":"2024-06-07","current":-4.028119,"twenty":-5.351408,"median":-4.637315,"eighty":-4.062533,"marketCap":214074398},{"date":"2024-06-14","current":-2.746826,"twenty":-5.256939,"median":-4.498493,"eighty":-3.894843,"marketCap":145980047},{"date":"2024-06-21","current":-1.997311,"twenty":-5.233547,"median":-4.480499,"eighty":-3.836344,"marketCap":106147077},{"date":"2024-06-28","current":-1.62046,"twenty":-5.185863,"median":-4.433265,"eighty":-3.622795,"marketCap":86119326},{"date":"2024-07-05","current":-1.737702,"twenty":-5.126483,"median":-4.318554,"eighty":-2.862394,"marketCap":92350182},{"date":"2024-07-12","current":-1.708392,"twenty":-5.081498,"median":-4.206091,"eighty":-2.280368,"marketCap":90792468},{"date":"2024-07-19","current":-1.490655,"twenty":-5.078799,"median":-4.082382,"eighty":-1.861645,"marketCap":79220879},{"date":"2024-07-26","current":-1.553464,"twenty":-5.032015,"median":-4.019745,"eighty":-1.783761,"marketCap":82558837},{"date":"2024-08-02","current":-1.33154,"twenty":-4.961394,"median":-3.883354,"eighty":-1.756126,"marketCap":70764718},{"date":"2024-08-09","current":-1.285481,"twenty":-4.955327,"median":-3.848068,"eighty":-1.688293,"marketCap":68316881},{"date":"2024-08-16","current":-1.276053,"twenty":-4.909884,"median":-3.776885,"eighty":-1.61376,"marketCap":73657615},{"date":"2024-08-23","current":-1.441824,"twenty":-4.830482,"median":-3.580085,"eighty":-1.533365,"marketCap":83226429},{"date":"2024-08-30","current":-1.395563,"twenty":-4.789503,"median":-2.891285,"eighty":-1.49233,"marketCap":80556062},{"date":"2024-09-06","current":-1.206661,"twenty":-4.774615,"median":-2.543744,"eighty":-1.430642,"marketCap":69652065},{"date":"2024-09-13","current":-1.383997,"twenty":-4.747457,"median":-2.265294,"eighty":-1.38631,"marketCap":79888471},{"date":"2024-09-20","current":-1.696264,"twenty":-4.696317,"median":-1.886349,"eighty":-1.383997,"marketCap":97913446},{"date":"2024-09-27","current":-1.306894,"twenty":-4.531782,"median":-1.821447,"eighty":-1.360095,"marketCap":75437859},{"date":"2024-10-04","current":-1.225936,"twenty":-4.502092,"median":-1.785855,"eighty":-1.334651,"marketCap":70764718},{"date":"2024-10-11","current":-1.164254,"twenty":-4.498493,"median":-1.762826,"eighty":-1.315376,"marketCap":67204229},{"date":"2024-10-18","current":-1.175819,"twenty":-4.494894,"median":-1.752358,"eighty":-1.306512,"marketCap":67871820},{"date":"2024-10-25","current":-1.125702,"twenty":-4.475101,"median":-1.708392,"eighty":-1.277939,"marketCap":64978923},{"date":"2024-11-01","current":-1.148833,"twenty":-4.453508,"median":-1.660521,"eighty":-1.239044,"marketCap":66314106},{"date":"2024-11-08","current":-1.278189,"twenty":-4.445411,"median":-1.62046,"eighty":-1.227478,"marketCap":78044967},{"date":"2024-11-15","current":-1.099243,"twenty":-4.400426,"median":-1.603711,"eighty":-1.225936,"marketCap":67118671},{"date":"2024-11-22","current":-0.858213,"twenty":-4.337447,"median":-1.553464,"eighty":-1.206661,"marketCap":52401620},{"date":"2024-11-29","current":-0.996988,"twenty":-4.287064,"median":-1.515072,"eighty":-1.18353,"marketCap":60875074},{"date":"2024-12-06","current":-1.033507,"twenty":-4.282566,"median":-1.492749,"eighty":-1.171964,"marketCap":63104930},{"date":"2024-12-13","current":-0.898385,"twenty":-4.206091,"median":-1.45339,"eighty":-1.168109,"marketCap":54854462},{"date":"2024-12-20","current":-0.94586,"twenty":-4.174602,"median":-1.427126,"eighty":-1.164254,"marketCap":57753275},{"date":"2024-12-27","current":-0.931252,"twenty":-4.109824,"median":-1.4052,"eighty":-1.151917,"marketCap":56861333},{"date":"2025-01-03","current":-0.978728,"twenty":-4.080133,"median":-1.38978,"eighty":-1.137518,"marketCap":59760146},{"date":"2025-01-10","current":-0.883777,"twenty":-4.053929,"median":-1.382892,"eighty":-1.125702,"marketCap":53962520},{"date":"2025-01-17","current":-0.923948,"twenty":-4.024769,"median":-1.357011,"eighty":-1.113366,"marketCap":56415361},{"date":"2025-01-24","current":-0.880125,"twenty":-4.002159,"median":-1.351229,"eighty":-1.080253,"marketCap":53739534},{"date":"2025-01-31","current":-0.836301,"twenty":-3.925951,"median":-1.335808,"eighty":-1.010135,"marketCap":51063706},{"date":"2025-02-07","current":-0.810737,"twenty":-3.894843,"median":-1.330025,"eighty":-0.986762,"marketCap":49502807},{"date":"2025-02-14","current":-0.818041,"twenty":-3.863491,"median":-1.312677,"eighty":-0.98238,"marketCap":49948778},{"date":"2025-02-21","current":-0.715786,"twenty":-3.86063,"median":-1.307149,"eighty":-0.967772,"marketCap":43705181},{"date":"2025-02-28","current":-0.70483,"twenty":-3.848068,"median":-1.306417,"eighty":-0.938556,"marketCap":43036224},{"date":"2025-03-07","current":-0.617183,"twenty":-3.818758,"median":-1.293401,"eighty":-0.934904,"marketCap":37684569},{"date":"2025-03-14","current":-0.613531,"twenty":-3.802009,"median":-1.278189,"eighty":-0.9276,"marketCap":37461584},{"date":"2025-03-21","current":-0.642747,"twenty":-3.751762,"median":-1.256474,"eighty":-0.920296,"marketCap":39245469},{"date":"2025-03-28","current":-0.511724,"twenty":-3.651268,"median":-1.237502,"eighty":-0.912992,"marketCap":33447843},{"date":"2025-04-04","current":-0.443494,"twenty":-3.580085,"median":-1.233647,"eighty":-0.891081,"marketCap":28988130},{"date":"2025-04-11","current":-0.416203,"twenty":-3.232545,"median":-1.225936,"eighty":-0.861865,"marketCap":27204245},{"date":"2025-04-17","current":-0.484432,"twenty":-3.075105,"median":-1.212454,"eighty":-0.839223,"marketCap":31663958},{"date":"2025-04-25","current":-0.50149,"twenty":-2.80461,"median":-1.206661,"eighty":-0.818041,"marketCap":32778886},{"date":"2025-05-02","current":-0.547545,"twenty":-2.616184,"median":-1.18353,"eighty":-0.802703,"marketCap":35789192},{"date":"2025-05-09","current":-0.490678,"twenty":-2.519877,"median":-1.175819,"eighty":-0.736237,"marketCap":32233147},{"date":"2025-05-16","current":-0.562236,"twenty":-2.343176,"median":-1.171964,"eighty":-0.7041,"marketCap":36933814},{"date":"2025-05-23","current":-0.531568,"twenty":-2.272831,"median":-1.168109,"eighty":-0.640556,"marketCap":34919242},{"date":"2025-05-30","current":-0.398676,"twenty":-2.104504,"median":-1.164254,"eighty":-0.625217,"marketCap":26189432},{"date":"2025-06-06","current":-0.398676,"twenty":-1.939527,"median":-1.156544,"eighty":-0.615722,"marketCap":26189432},{"date":"2025-06-13","current":-0.371416,"twenty":-1.883418,"median":-1.150761,"eighty":-0.59381,"marketCap":24398701}],"updateTime":1749933837320}}}